Evidence map›Paper›PMID 35578145›Full record

ArticleInternational journal of clinical pharmacy2022

Polypharmacy and potentially inappropriate medications in stroke rehabilitation: prevalence and association with outcomes.

Ayaka Matsumoto, Yoshihiro Yoshimura, Fumihiko Nagano, Takahiro Bise, Yoshifumi Kido, Sayuri Shimazu, Ai Shiraishi

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ayaka MatsumotoDepartment of Pharmacy, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Yoshihiro YoshimuraCenter for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, 760 Magate, Kikuyo-Town, Kikuchi-County, Kumamoto, 869-1106, Japan. hanley.belfus@gmail.com.ORCID http://orcid.org/0000-0001-7545-4179
Fumihiko NaganoDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Takahiro BiseDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Yoshifumi KidoDepartment of Rehabilitation, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Sayuri ShimazuDepartment of Nutritional Management, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Ai ShiraishiDepartment of Dental Office, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
KM Biologics (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Evidence is scarce regarding polypharmacy and potentially inappropriate medications (PIMs) in rehabilitation medicine. Aim To investigate the prevalence of polypharmacy and PIMs and their association with outcomes in stroke rehabilitation. Method A retrospective cohort study was conducted with 849 older inpatients post-stroke. Polypharmacy was defined as six or more medications, and PIMs were defined based on Beers criteria 2019. Study outcomes included functional independence measure (FIM)-motor, FIM-cognitive, energy intake, dysphagia, length of hospital stay, and the rate of home discharge. To consider the effect of pharmacotherapy during rehabilitation, multivariate analyses were used to determine whether the presence of polypharmacy or PIMs at discharge was associated with outcomes. Results After enrollment, 361 patients (mean age 78.3 ± 7.7 years; 49.3% male) were analyzed. Polypharmacy was observed in 43.8% and 62.9% of patients, and any PIMs were observed in 64.8% and 65.4% of patients at admission and discharge, respectively. The most frequently prescribed PIMs included antipsychotics, benzodiazepines, and proton pump inhibitors. Polypharmacy was negatively associated with FIM-motor score (β = - 0.062, P = 0.049), FIM-cognitive score (β = - 0.076, P = 0.014), energy intake (β = - 0.143, P = 0.005), and home discharge (OR: 0.458; 95% CI: 0.248, 0.847; P = 0.013). PIMs were negatively associated with home discharge (OR: 0.375; 95% CI: 0.195, 0.718; P = 0.003). Conclusion Polypharmacy and PIMs are commonly found among older patients undergoing stroke rehabilitation. Moreover, polypharmacy was negatively associated with activities of daily living (ADL) but not with PIMs and ADLs, and both were associated with home discharge.

Indexed as

Potentially Inappropriate Medication ListStroke RehabilitationActivities of Daily LivingAgedAged, 80 and overFemaleHumansInappropriate PrescribingMalePolypharmacyPrevalenceRetrospective StudiesActivities of daily livingBeers criteriaGeriatric rehabilitationMultimorbidityPolymedicationPotentially inappropriate medications

Identifiers

PMID35578145
OpenAlexW4280495480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.